quantitative
Analysis v1
Strong Support
A weekly diabetes shot called exenatide doesn’t seem to lower the risk of serious kidney problems in adults with type 2 diabetes when looking at the raw data. But when researchers adjusted the numbers, it showed a small benefit when including a wider range of kidney issues, like high protein in the urine.
82
0
Evidence from Studies
Supporting (1)
82
Community contributions welcome
82
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
Randomized Controlled Trial
Human
2020 FebThe study looked at a weekly diabetes shot called exenatide and found it didn’t clearly protect kidneys unless they used special number adjustments, which matches what the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.